Shen Bo, Fazio Victor W, Remzi Feza H, Bennett Ana E, Lavery Ian C, Lopez Rocio, Brezinski Aaron, Sherman Kerry K, Bambrick Marlene L, Lashner Bret A
Center for Inflammatory Bowel Disease, Department of Gastroenterology/Hepatology, Cleveland Clinic, Cleveland, OH 44195, USA.
Dis Colon Rectum. 2007 Sep;50(9):1450-9. doi: 10.1007/s10350-007-0284-8.
Crohn's disease of the pouch can occur in patients with colectomy and ileal pouch-anal anastomosis performed for ulcerative colitis. The clinical features of inflammatory, fibrostenotic, and fistulizing Crohn's disease have not been characterized.
A total of 73 eligible patients with Crohn's disease of the pouch, who were seen in the Pouchitis Clinic, were enrolled: 25 with inflammatory Crohn's disease, 17 with fibrostenotic Crohn's disease, and 31 with fistulizing Crohn's disease. The clinical phenotypes of Crohn's disease were based on a combined assessment of clinical, endoscopic, radiographic, and histologic features. Clinical symptoms, endoscopic and histologic features, and health-related quality-of-life scores were assessed.
Demographic and clinical features, including preoperative and postoperative parameters, were similar between the three phenotypes of Crohn's disease of the pouch. The use of nonsteroidal anti-inflammatory drugs, neuropsychiatric drugs, antidiarrheal agents, and Crohn's disease medicines was not different between the three groups. Predominant symptoms, as expected, were significantly different between the three phenotypes: diarrhea and/or pain in 92 percent of patients with inflammatory Crohn's disease, obstructive symptoms in 64.7 percent of patients with fibrostenotic Crohn's disease, and fistular drainage in 51.6 percent of those with fistulizing Crohn's disease (P < 0.0001). There was no statistical difference in quality-of-life scores between the three phenotypes, adjusted for disease activity. There was no significant correlation between quality-of-life and symptom scores in any of the three groups. Although not statistically significant, patients with fistulizing Crohn's disease (16.1 percent) tended to have an increased risk for pouch failure compared with inflammatory (8 percent) or fibrostenotic (5.9 percent) Crohn's disease.
Predominant symptoms were different in clinical phenotypes of Crohn's disease. Each of the three phenotypes of Crohn's disease similarly affected quality-of-life. Fistulizing Crohn's disease may be associated with a higher risk for pouch failure.
结肠切除术后行回肠储袋肛管吻合术的溃疡性结肠炎患者可能发生储袋克罗恩病。炎症性、纤维狭窄性和瘘管性克罗恩病的临床特征尚未明确。
共有73例符合条件的储袋克罗恩病患者纳入研究,这些患者均在储袋炎门诊就诊,其中25例为炎症性克罗恩病,17例为纤维狭窄性克罗恩病,31例为瘘管性克罗恩病。克罗恩病的临床表型基于临床、内镜、影像学和组织学特征的综合评估。评估临床症状、内镜和组织学特征以及健康相关生活质量评分。
储袋克罗恩病三种表型之间的人口统计学和临床特征,包括术前和术后参数,相似。三组之间非甾体类抗炎药、神经精神药物、止泻剂和克罗恩病药物的使用无差异。正如预期的那样,三种表型的主要症状有显著差异:92%的炎症性克罗恩病患者有腹泻和/或疼痛,64.7%的纤维狭窄性克罗恩病患者有梗阻症状,51.6%的瘘管性克罗恩病患者有瘘管引流(P<0.0001)。调整疾病活动度后,三种表型的生活质量评分无统计学差异。三组中任何一组的生活质量与症状评分之间均无显著相关性。虽然无统计学意义,但与炎症性(8%)或纤维狭窄性(5.9%)克罗恩病相比,瘘管性克罗恩病患者(16.1%)储袋失败风险有增加趋势。
克罗恩病临床表型的主要症状不同。克罗恩病的三种表型对生活质量的影响相似。瘘管性克罗恩病可能与储袋失败风险较高有关。